Literature DB >> 3962892

Noninvasive detection of coronary artery patency using continuous ST-segment monitoring.

M W Krucoff, C E Green, L F Satler, F C Miller, R S Pallas, K M Kent, A A Del Negro, D L Pearle, R D Fletcher, C E Rackley.   

Abstract

Continuous ST-segment Holter recordings were analyzed from 46 patients with acute myocardial infarction (AMI) receiving intracoronary streptokinase (SK) during the first 48 hours of hospitalization. Changes in ST deviation and the time periods of these changes were quantitated and correlated with angiographic evidence of reperfusion. Thirty-six patients had total occlusion of the infarct vessel and 10 had subtotal occlusion. Of the 36 vessels that were totally occluded, 19 were reperfused and 17 were not. In patients in whom reperfusion was successful, an ST steady state was achieved 55 +/- 32 minutes after SK administration. In patients in whom it was not successful, a steady state was achieved in 219 +/- 141 minutes (p less than 0.001). Achievement of steady state within 100 minutes after SK reperfusion indicated successful reperfusion with 89% sensitivity and 82% specificity. All patients with subtotal occlusion achieved an ST steady state before SK infusion. No patient with total occlusion achieved a steady state before SK. Achievement of ST steady state before SK infusion was 100% sensitive and 100% specific for subtotal occlusion at initial angiography. Continuous, quantitative ST-segment analysis is a sensitive and specific noninvasive technique for following coronary artery patency during AMI.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3962892     DOI: 10.1016/0002-9149(86)90730-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  ECG monitoring, biochemical Testing, and Anticoagulation Assessment.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi; Y Birnbaum
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

3.  French multicenter trial of anistreplase versus heparin in acute myocardial infarction.

Authors:  H Lardoux; Y Louvard; D de Vernejoul; C Picot; M Baudet; M Hiltgen; M Houplon; J Ponsonnaille; M Richard; R Luccioni
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

4.  Prognostic significance of the distortion of terminal portion of QRS complex on admission electrocardiogram in ST segment elevation myocardial infarction.

Authors:  Dnyaneshwar V Mulay; Sachin M Mukhedkar
Journal:  Indian Heart J       Date:  2013-11-01

5.  Evaluation of mortality and morbidity during four years after late thrombolysis in acute myocardial infarct.

Authors:  A Liguori; F DiGregorio; C Napoli
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

Review 6.  [Enzymatic markers of reperfusion in acute myocardial infarct. With data from the ISAM study].

Authors:  S Walter; J Carlsson; R Schröder; K L Neuhaus; E Sorges; U Tebbe
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

7.  Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function.

Authors:  R K Saran; M Been; S S Furniss; T Hawkins; D S Reid
Journal:  Br Heart J       Date:  1990-08

8.  Failure of thrombolysis by streptokinase: detection with a simple electrocardiographic method.

Authors:  A G Sutton; P G Campbell; D J Price; E D Grech; J A Hall; A Davies; M J Stewart; M A de Belder
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

9.  ST variability during the first 4 hours of acute myocardial infarction predicts 1-year mortality.

Authors:  P Johanson; K Swedberg; M Dellborg
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-07       Impact factor: 1.468

10.  Are enzymatic tests good indicators of coronary reperfusion?

Authors:  H A Bosker; A van der Laarse; V M Cats; A V Bruschke
Journal:  Br Heart J       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.